1. Home
  2. CTKB vs VINP Comparison

CTKB vs VINP Comparison

Compare CTKB & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • VINP
  • Stock Information
  • Founded
  • CTKB 1990
  • VINP 2009
  • Country
  • CTKB United States
  • VINP Brazil
  • Employees
  • CTKB N/A
  • VINP N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • VINP Investment Managers
  • Sector
  • CTKB Health Care
  • VINP Finance
  • Exchange
  • CTKB Nasdaq
  • VINP Nasdaq
  • Market Cap
  • CTKB 718.8M
  • VINP 616.8M
  • IPO Year
  • CTKB 2021
  • VINP 2021
  • Fundamental
  • Price
  • CTKB $2.93
  • VINP $10.09
  • Analyst Decision
  • CTKB Buy
  • VINP Strong Buy
  • Analyst Count
  • CTKB 2
  • VINP 2
  • Target Price
  • CTKB $7.00
  • VINP $13.25
  • AVG Volume (30 Days)
  • CTKB 659.9K
  • VINP 61.5K
  • Earning Date
  • CTKB 05-08-2025
  • VINP 05-12-2025
  • Dividend Yield
  • CTKB N/A
  • VINP 6.44%
  • EPS Growth
  • CTKB N/A
  • VINP N/A
  • EPS
  • CTKB N/A
  • VINP 0.34
  • Revenue
  • CTKB $197,050,000.00
  • VINP $97,136,413.00
  • Revenue This Year
  • CTKB $4.02
  • VINP $27.12
  • Revenue Next Year
  • CTKB $8.47
  • VINP $16.70
  • P/E Ratio
  • CTKB N/A
  • VINP $30.00
  • Revenue Growth
  • CTKB N/A
  • VINP 32.21
  • 52 Week Low
  • CTKB $3.27
  • VINP $8.66
  • 52 Week High
  • CTKB $7.63
  • VINP $11.62
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 26.81
  • VINP 61.88
  • Support Level
  • CTKB $3.64
  • VINP $9.56
  • Resistance Level
  • CTKB $3.89
  • VINP $9.89
  • Average True Range (ATR)
  • CTKB 0.18
  • VINP 0.28
  • MACD
  • CTKB -0.02
  • VINP 0.07
  • Stochastic Oscillator
  • CTKB 5.08
  • VINP 96.15

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About VINP Vinci Partners Investments Ltd.

Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Market; Liquid Strategies; Investment Products and solutions; Financial Advisory; and Retirement Services. The company's majority of its revenue comes from the Private Market segment which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.

Share on Social Networks: